AI Software for Hematology
Powered with Artificial Intelligence. Built for Human Intelligence.
AI Software for Hematology from Unlimited Systems reads infusion and injection records and drafts drug units, waste lines, and administration codes. It predicts denial risk on specialty drug claims and suggests the next step on each one. Hematology revenue turns on lab values, dosing schedules, and approvals that follow a specific drug and dose. Unlimited AI checks every claim against them. Your team spends its time on patients and on the drug claims that need a decision.
The Practical Side of AI for Specialty Practices
Avoid the pitfalls, cut through the noise, and put AI to work on everyday challenges. With Johnathon Trout (JT), Director of Product Management.
AI Built Around the Realities of Hematology
A hematology practice sees patients again and again for iron, ESA injections, transfusions, factor products, and lab checks. Doses often depend on weight or lab values that change between visits. Payers approve a specific drug, dose, and number of doses. A regimen change can make an approval stale without anyone noticing. AI helps by matching each dose to the labs, approvals, and payer rules that apply, and raising only the ones that do not line up.
- For Medicare, ESA claims for non-ESRD patients must report the latest hemoglobin or hematocrit and an EA, EB, or EC modifier.
- IV iron products such as iron sucrose and ferric carboxymaltose often need recent iron studies on file before approval.
- Drug units come from the dose given and the HCPCS descriptor. Under Medicare Part B, single-dose vials need JW for waste or JZ when none was discarded.
- Infusion administration codes follow a hierarchy of initial, sequential, and concurrent services, driven by start and stop times.
- Bone marrow aspiration and biopsy at the same session are reported together with code 38222.
- Some payers require certain specialty drugs to come through a designated pharmacy instead of buy-and-bill.
Where AI Can Improve Hematology Operations
- Problem
- ESA claims for Medicare patients need the latest hemoglobin or hematocrit and the right anemia modifier. Missing either one sends a clean dose back as a denial.
- Automation + Intelligence
- Before the claim is built, the latest lab value is pulled from the lab record and checked against the payer's coverage rule. The draft carries the EA, EB, or EC modifier the documented cause of anemia supports. Claims with a missing value are held with the reason.
- Human Benefit
- Billers stop looking up lab results to finish ESA claims.
- Business Benefit
- Fewer ESA denials for missing lab data or modifiers.
- Problem
- IV iron and specialty drugs need approvals tied to lab thresholds and prior therapy. When a regimen changes, the old approval may no longer cover the dose.
- Automation + Intelligence
- AI prior authorization checks each drug order against payer rules and gathers the iron studies, hemoglobin trends, and therapy history the payer asks for. Approvals are tracked by drug, dose, and number of doses. A scheduled dose that falls outside the approval is flagged before the patient arrives.
- Human Benefit
- Prior auth staff fix a stale approval before the infusion, not after the denial.
- Business Benefit
- High-cost doses stay covered by a valid approval.
- Problem
- Drug units keyed from the order instead of the administration record are a common source of error. Waste from single-dose vials is often left off or reported without its own line.
- Automation + Intelligence
- Units are drafted from the dose recorded at administration and the HCPCS descriptor. For single-dose containers, a JW waste line or a JZ modifier is drafted as the record supports. Each line cites the administration entry behind it.
- Human Benefit
- Nurses and coders no longer recalculate units by hand for each infusion.
- Business Benefit
- Drug lines bill as given, with waste reported the way Medicare and adopting payers expect.
- Problem
- A single visit can combine an IV iron infusion, hydration, an injection, and a lab draw. Administration codes that ignore the hierarchy are paid wrong or denied.
- Automation + Intelligence
- Unlimited AI reads start and stop times and drafts initial, sequential, and concurrent administration codes in the right order. Same-day visit and procedure pairs are checked against coding edits before the claim is built.
- Human Benefit
- Coders confirm a cited draft rather than piecing times together from nursing notes.
- Business Benefit
- Administration revenue matches the care delivered.
- Problem
- Drug payments drive hematology margin. A payment below the expected rate, or below what the practice paid, can pass as normal.
- Automation + Intelligence
- Each drug line is checked against its expected reimbursement and acquisition cost when the remittance posts. Shortfalls and possible negative-margin drugs are flagged. Denials tied to lab values or frequency limits go straight to a correction queue with the lab results attached.
- Human Benefit
- Billing managers see drug payment problems as they happen.
- Business Benefit
- Underpaid drug lines are appealed promptly, and contract issues surface with the data behind them.
- Problem
- Hematology AR holds a small number of high-value drug claims among many routine visits. One denied factor or iron claim can outweigh many office visits.
- Automation + Intelligence
- Every drug claim gets a denial risk score before submission. The open drug claims are then ordered by value at risk and filing deadline. Drug denials arrive with the likely cause and the lab and approval records needed to appeal.
- Human Benefit
- Collectors work the large drug claims before they near a filing limit.
- Business Benefit
- Drug revenue is not left aging behind small visit balances.
The Evolution of Intelligence in Hematology
Eligibility, drug approval checks, and claim status requests run on their own for every infusion, injection, and transfusion visit.
ESA claims without a current lab value, doses outside an approval, and units that do not match the administration record are flagged.
Denied drug claims and approvals near their dose limit move ahead of routine visit claims.
Each flagged claim names its fix, such as the lab value to report, the approval to update, or the waste line to add.
Emerging capability: approval updates for a routine dose change could be drafted and sent on their own when the labs on file meet the payer's criteria. The design allows it, but it is not a live feature.
Work by Exception for Hematology
A Medicare patient without ESRD is due for a darbepoetin dose. The draft claim has no hemoglobin value because the latest lab result has not posted to the chart.
Unlimited AI holds only that claim and tells the biller which lab value is missing. The day's iron infusions and other injections that pass their checks move forward with no manual review.
AI Matches Doses to Labs. Your Hematology Team Focuses on Patients.
Hematology patients often live with chronic blood disorders and return for care many times. Nurses should be watching them in the chair. Clinicians should be reading lab trends and adjusting treatment. Neither should be chasing a hemoglobin value to finish a claim. Automation handles the dose, lab, and approval matching. Every unclear unit, payer rule, or appeal still goes to a person who knows the patient.
AI Across the Hematology Revenue Cycle
Why Unlimited Systems for Hematology
- ESA lab reporting and anemia modifiers are checked against the lab record before a claim is built.
- Drug approvals are tracked by drug, dose, and number of doses, with alerts when a regimen changes.
- Units and JW or JZ reporting come from the administration record for each single-dose container.
- Drug payments are compared with expected reimbursement and acquisition cost at posting.
- Every drafted unit and code cites the record it came from, and the AI runs on a private, audited instance that keeps no patient data for training.
Frequently Asked Questions About AI for Hematology
AI software for hematology applies automation and machine learning to the drug, lab, and approval work in a blood disorder practice. Unlimited AI drafts drug units, waste lines, and administration codes from the record. It checks ESA claims for required lab values, tracks approvals by drug and dose, and predicts which claims will deny. Staff review only the doses and claims with a real problem.
Under Medicare, an ESA claim for a patient without ESRD needs the latest hemoglobin or hematocrit and an anemia modifier: EA, EB, or EC. The platform pulls the latest value from the lab record and checks it against the payer's coverage rule. The draft carries the modifier that the documented cause of anemia supports. Claims missing a value are held with the reason.
AI prior authorization checks each IV iron or specialty drug order against payer rules. It gathers the iron studies, hemoglobin trends, and prior therapy history payers ask for. Each approval is tracked by drug, dose, and number of doses. When a regimen changes or a scheduled dose would fall outside the approval, staff are alerted before the patient arrives.
Drug units are drafted from the dose recorded at administration and the HCPCS code descriptor, not from the order. For single-dose containers, the platform drafts a separate JW line for discarded drug or applies JZ when nothing was discarded, as Medicare Part B requires. Each line cites the administration entry, so a reviewer can trace it back.
Bone marrow aspiration and biopsy done at the same session are reported together with code 38222, and the platform checks for that pairing. Infusion administration codes are drafted from start and stop times in the order the hierarchy requires: initial, sequential, then concurrent. Same-day visit and procedure pairs are checked against coding edits before the claim goes out.
Drug margin can slip when payments fall below expected rates or acquisition cost. The platform compares each drug payment with its expected reimbursement as remittances post. Shortfalls and possible negative-margin drugs are flagged for follow-up. Margin reports by drug and payer help the practice prepare for contract talks and site-of-care decisions.
Hematology billers work a short list instead of the whole schedule. AI drafts units and codes, checks labs and approvals, and sorts drug denials by value and deadline. Billers handle appeals, assistance program matching, and payer calls that need judgment. Every automated change is logged, and anything uncertain goes to a person who can decide it.
GET STARTED
See What AI Can Do for Your Hematology Practice
AI Software for Hematology from Unlimited Systems reads infusion and injection records and drafts drug units, waste lines, and administration codes. It predicts denial risk on specialty drug claims and suggests the next step on each one. Hematology revenue turns on lab values, dosing schedules, and approvals that follow a specific drug and dose. Unlimited AI checks every claim against them. Your team spends its time on patients and on the drug claims that need a decision.
6,500+ specialty providers